HPV-RELATED SQUAMOUS CELL CARCINOMA
Clinical trials for HPV-RELATED SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized T-Cell army takes on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new treatment called T-Plex for people with advanced solid tumors that have not responded to standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab to recognize and attack multiple cancer-related targets. Th…
Matched conditions: HPV-RELATED SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Triple threat: vaccine, immunotherapy, and Chemo-Radiation take on HPV head and neck cancer
Disease control OngoingThis study tests a new treatment for a type of head and neck cancer caused by HPV. It combines a vaccine that targets the cancer cells, an immunotherapy drug (pembrolizumab), and standard chemo-radiation. The goal is to see if this combination can better control the cancer and pr…
Matched conditions: HPV-RELATED SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated May 04, 2026 16:20 UTC